This inventor holds 2 USPTO granted patents. Top assignee: Cerner Innovation, Inc.. Active years: 2010-2014.
Company Filing History:
Years Active: 2010-2014
Title: Innovations by Peter Young in Informed Consent Processes
Introduction
Peter Young is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of informed consent processes, holding a total of 2 patents. His work focuses on improving the management of informed consent documentation, which is crucial in medical trials and procedures.
Latest Patents
Peter Young's latest patents revolve around methods and systems for managing informed consent processes. These systems provide a dynamic process for obtaining and managing informed consent documentation. The dynamic informed consent process (DICP) utilizes an intermediary organization, such as a trusted intermediary, to provide informed consent forms (ICFs) that are dynamically generated for specific trials or medical procedures. These forms are based on particular state or federal requirements, if applicable. Additionally, the system archives copies of signed ICFs. The process may also include providing training materials, such as audio or video presentations, for prospective participants. Furthermore, it includes a procedure for contacting subjects who have signed ICFs in the event of any changes that may affect their consent.
Career Highlights
Peter Young is currently employed at Cerner Innovation, Inc., where he continues to develop innovative solutions in healthcare technology. His work has been instrumental in enhancing the efficiency and effectiveness of informed consent processes.
Collaborations
Some of Peter's notable coworkers include Andrea Califano and Aristidis Floratos, who contribute to the collaborative environment at Cerner Innovation, Inc.
Conclusion
Peter Young's contributions to the field of informed consent processes demonstrate his commitment to innovation in healthcare. His patents reflect a forward-thinking approach that enhances the way informed consent is managed, ultimately benefiting both participants and researchers.